Study of Outcomes and Side Effects in Patients Receiving Radiation Therapy at Winterthur Cantonal Hospital from 2000 to 2025
Led by Daniel Zwahlen · Updated on 2025-05-21
25000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are analyzing the outcomes and side effects experienced by patients undergoing radiation therapy. This observational study uses a database of patient records from the year 2000 to 2025 to systematically record and evaluate treatment results and adverse events. The goal is to improve the quality of radiotherapy and reduce serious side effects for future patients through detailed data analysis and quality control.
The study collects data from patients treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital. It focuses on tracking overall survival and progression-free survival over 25 years, while also identifying risk factors that influence treatment outcomes. The study also monitors both acute and late adverse events related to radiation therapy.
Participants personal and treatment-related data are systematically recorded and analyzed to assess the effectiveness and safety of radiotherapy. The study evaluates outcomes such as survival rates and side effects to inform future improvements in care. This long-term data collection and analysis supports quality assurance and contributes to clinical research at the Institute for Radio-Oncology.
CONDITIONS
Brief Title
Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy
Research Team
D
Daniel R Zwahlen, MD, MBA
R
Romy Frey
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients who are being treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital
You will not qualify if you...
Patients not treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital
Age younger than 16 years
Age older than 105 years
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring
Duration - Up to 25 years
Participants who undergo routine radiotherapy are observed to record outcomes and adverse events over time.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Comparing 3-Needle and 5-Needle Genicular Nerve Blocks for Pain and Quality of Life in Knee Osteoarthritis
Community-Based Digital and Behavioral Management for Nocturia in Older Adults
Web-Based Light, Activity, and Sleep Program to Improve Quality of Life in Adults 70 and Older
Randomized Trial of Peer-Led CARE Intervention to Improve Health and Reduce Cardiovascular Risks in Women Ages 18 to 49 in Texas Communities
Study of Brain Stimulation and Virtual Reality Cognitive Training to Improve Thinking and Mood in Adults 55 and Older with Mild Cognitive Impairment
Phase 2 Study of Enalapril for Adults Aged 18 to 70 With Painful Venous Malformations to Reduce Pain and Improve Quality of Life
Acceptance and Commitment Therapy to Support Mental Health and Transition Readiness
in Black Adolescents and Young Adults with Sickle Cell Disease
MRI-Guided Adaptive Radiotherapy Compared to Standard Radiotherapy for Advanced Oropharynx Cancer A Phase II Randomized Study
Study of Brandt-Daroff Exercises Combined With GANS Maneuver to Reduce Dizziness and Improve Quality of Life in Adults With BPPV
Adebrelimab Plus Chemotherapy Before Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma
A Single-Group Exploratory Study at Shandong University
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation.